[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-364009-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-364009-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","spatial-modulation-of-raf-by-rafmek-glue-enables-full-dose-combination-with-pan-raf-inhibitor-and-potent-ras-mutant-tumor-selective-mapk-and-growth-inhibition","Spatial modulation of RAF by RAF/MEK glue enables full-dose combination with pan-RAF inhibitor and potent RAS-mutant tumor-selective MAPK and growth inhibition","","MAPK-targeted therapies benefit patients only when tumors experience stronger pathway inhibition than normal tissues. Pan-RAF inhibitors work in RAS-mutant cancers, but pairing them with MEK inhibitors often forces dose reductions because toxicity limits the therapeutic window. The study links toxicity to MEK inhibitor feedback relief that enhances RAF activation and pan-RAF inhibitor binding in normal cells. It shows MEK is cytosolic and uses RAF/MEK glues to spatially trap cytosolic RAF–MEK complexes, preserving inhibition in tumors while blocking feedback-driven activation in healthy tissue, enabling full-dose combination.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/spatial-modulation-of-raf-by-rafmek-glue-enables-full-dose-combination-with-pan-raf-inhibitor-and-potent-ras-mutant-tumor-selective-mapk-and-growth-inhibition/364009/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/spatial-modulation-of-raf-by-rafmek-glue-enables-full-dose-combination-with-pan-raf-inhibitor-and-potent-ras-mutant-tumor-selective-mapk-and-growth-inhibition/364009.png","ImageObject",300,407,{"name":42,"@type":43},"OmBimo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why do pan-RAF inhibitors combined with MEK inhibitors often require dose reductions?","Question",{"text":63,"@type":64},"The toxicity arises from MEK inhibitor–mediated feedback relief that promotes RAF activation and increases pan-RAF inhibitor engagement in normal cells, narrowing the therapeutic index.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is the key mechanistic limitation addressed by the study regarding MEK?",{"text":68,"@type":64},"MEK is shown to be exclusively cytosolic. RAF/MEK glues overcome this by spatially trapping RAF–MEK complexes in the cytosol.",{"name":70,"@type":61,"acceptedAnswer":71},"How do RAF/MEK glues enable full-dose pan-RAF plus MEK-targeted combination?",{"text":72,"@type":64},"By stabilizing cytosolic RAF–MEK complexes, RAF/MEK glues prevent feedback-driven RAF activation in normal cells while maintaining inhibition of oncogenic RAF signaling in RAS-mutant tumors, where RAF is constitutively active at the plasma membrane.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},364009,1790571435,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":102,"preview_urls":146},962090893581,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","bioRxiv preprint doi: [https://doi.org/10.64898/2026.07.24.740654](https://doi.org/10.64898/2026.07.24.740654); this version posted July 27, 2026. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made  \navailable under a CC-BY-ND 4.0 International license.  \nSpatial modulation of RAF by RAF/MEK glue enables full-dose combination with panRAF inhibitor and potent RAS-mutant tumor-selective MAPK and growth inhibition  \nAna Orive-Ramos 1*, Bijaya Gaire 1*, Christos Adamopoulos 1,2*\\#, Beau Baars 1, Mathieu Desaunay1, Ziyue Kou 1, Evangelia Matenoglou3, Silvia Coma4, Nayeli Gutiérrez-Trejo 1, Kevin Mohammed 1, Stuart A. Aaronson 1, Jian Jin5, Tiphaine C. Martin 1, Ernesto Guccione 1, Evripidis Gavathiotis3, Jonathan A. Pachter4, Poulikos I. Poulikakos 1\\#  \n1. Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, NY, USA  \n2. Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Athens, Greece  \n3. Department of Biochemistry, Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, NY, USA  \n4. Verastem Oncology, Needham, MA, USA  \n5. Department of Pharmacology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, NY, USA  \n* Equal contribution  \n\\# [Correspondence to](Correspondence to poulikos.poulikakos@mssm.edu or cadamop@med.uoa.gr)[ ](Correspondence to poulikos.poulikakos@mssm.edu or cadamop@med.uoa.gr)[poulikos.poulikakos@mssm.edu](Correspondence to poulikos.poulikakos@mssm.edu or cadamop@med.uoa.gr)[ or](Correspondence to poulikos.poulikakos@mssm.edu or cadamop@med.uoa.gr)[ ](Correspondence to poulikos.poulikakos@mssm.edu or cadamop@med.uoa.gr)[cadamop@med.uoa.gr](Correspondence to poulikos.poulikakos@mssm.edu or cadamop@med.uoa.gr)  \nbioRxiv preprint doi: [https://doi.org/10.64898/2026.07.24.740654](https://doi.org/10.64898/2026.07.24.740654); this version posted July 27, 2026. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made  \navailable under a CC-BY-ND 4.0 International license.  \nAbstract  \nThe clinical benefit of MAPK-targeted therapies depends on greater pathway inhibition in tumors than normal tissues. Although pan-RAF inhibitors are active in RAS-mutant cancers, combining them with MEK inhibitors requires dose reductions due to toxicity, limiting efficacy. We show the toxicity results from MEK inhibitor–mediated feedback relief, which promotes RAF activation and pan-RAF inhibitor engagement in normal cells, narrowing the therapeutic index. We further demonstrate that MEK is exclusively cytosolic, and RAF/MEK glues overcome this limitation through spatial trapping. By stabilizing cytosolic RAF–MEK complexes, RAF/MEK glues prevent feedback-driven RAF activation in normal cells while maintaining inhibition of oncogenic RAF signaling in RAS-mutant tumors, where RAF is constitutively activated at the plasma membrane. Consequently, this enables full-dose combination with pan-RAF inhibitors, resulting in deeper MAPK suppression and robust tumor regressions in RAS-mutant models. Thus, by spatially controlling wild-type effectors, druginduced proximity can be harnessed to increase tumor selectivity of pathway-targeted therapies.  \nSignificance  \nMAPK-targeted therapies rarely achieve durable responses in RAS-mutant cancers due to doselimiting toxicities. We show that RAF/MEK glues, by spatially trapping RAF, can be combined with pan-RAF inhibitors at full dose, yielding tumor-selective MAPK inhibition and tumor regressions in RAS-mutant models. Thus, drug-induced proximity can be exploited for tumorselective therapy.  \nIntroduction  \nbioRxiv preprint doi: [https://doi.org/10.64898/2026.07.24.740654](https://doi.org/10.648","cbCaiiEQ1AxH53iC","https://ap.wps.com/l/cbCaiiEQ1AxH53iC","pdf",7748585,59,"English","# Abstract\n# Significance\n# Introduction\n# Results","[{\"question\":\"Why do pan-RAF inhibitors combined with MEK inhibitors often require dose reductions?\",\"answer\":\"The toxicity arises from MEK inhibitor–mediated feedback relief that promotes RAF activation and increases pan-RAF inhibitor engagement in normal cells, narrowing the therapeutic index.\"},{\"question\":\"What is the key mechanistic limitation addressed by the study regarding MEK?\",\"answer\":\"MEK is shown to be exclusively cytosolic. RAF/MEK glues overcome this by spatially trapping RAF–MEK complexes in the cytosol.\"},{\"question\":\"How do RAF/MEK glues enable full-dose pan-RAF plus MEK-targeted combination?\",\"answer\":\"By stabilizing cytosolic RAF–MEK complexes, RAF/MEK glues prevent feedback-driven RAF activation in normal cells while maintaining inhibition of oncogenic RAF signaling in RAS-mutant tumors, where RAF is constitutively active at the plasma membrane.\"}]","Spatial modulation of RAF by RAF/MEK glue enables full-dose combination with pan-RAF inhibitor and potent RAS-mutant tumor-selective MAPK and growth inhibition | PDF",1790155073,149,[147,151,155,159,163,167],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ea3eef39b189ea77e786812dd385efe6.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d7d443be6d0b6b82515b92de7fdd9a5b.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da57be8d36713a8edb0101e628fe98b3.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1fd4c05c64b6692fcebf9312e954ca15.webp",980,1268,{"page_no":97,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/584ac43d7c14c92838e820412588d8c4.webp",979,1267,{"page_no":102,"url":168,"width":169,"height":170},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0ea5e3948cc25d9a034ab8056ad7eb84.webp",978,1265]